Clinical application of therapy eliminating tuibidity and calming liver in treatment of essential hypertension with metabolic disorder

Zhongguo Zhongyao Zazhi

Volumn 38, Issue 8, 2013, Pages 1251-1254

  Liu, Wei ^a   Xiong, Xing Jiang ^a   Wang, Jie ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

Eliminating turbidity and calming liver; Hypertension; Metabolic disorders

Indexed keywords

ARTICLE; ESSENTIAL HYPERTENSION; METABOLIC DISORDER;

COMPLEMENTARY THERAPIES; HUMANS; HYPERTENSION; LIVER; MEDICINE, CHINESE TRADITIONAL;

EID: 84878075756     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: 10.4268/cjcmm20130826     Document Type: Article

References (49)

1. 2010, 30(5): 453.
2. Holmes E, Loo R L, Stamler J, et al. Human metabolic phenotype diversity and its association with diet and blood pressure[J]. Nature, 2008, 453(7193): 396.
3. 2011: 14.
4. 2008, 14(2): 80.
5. Calhoun D A, Zaman M A, Nishizaka M K. Resistant hypertension [J]. Curr Hyertens Rep, 2002, 4(3): 221.
6. 1999, 27(12): 17.
7. 2010, 35(4): 536.
8. 2009, 50(3): 197.
9. 2010, 8(1): 20.
10. Thompson A M, Hu T, Eshelbrenner C L, et al. Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension : a meta-analysis[J]. J Amer Med Assoc, 2011, 305(9): 913.
11. 2011, 31(8): 604.
12. Mansia G, De Backer G, Dominiczak A, et al. 2007Guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the european society of hypertension(ESH)and of the European society of cardiology(ESC)[J]. Eur Heart J, 2007, 28(12): 1462.
13. 2005, 13(8): 504.
14. Wilson P W, D Agostino R B, Sullivan L, et al. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience [J]. Arch Intern Med, 2002, 163(16): 1867.
15. Harsha D W, Bray G A. Weight loss and blood pressure control (Pro) [J]. Hypertension, 2008, 51(6): 1420.
16. 2009, 27(9): 32.
17. 2011, 52(23): 1985.
18. 2000, 15(3): 14.
19. 2009, 25(17): 2969.
20. 2007, 17(2): 8.
21. 2010, 26(5): 819.
22. 2010, 25(12): 1960.
23. K J Chen, K K Hui, M S Lee, et al. The potential benefit of complementary/alternative medicine in cardiovascular diseases [J]. Evid-Based Compl Alt Med, 2012, doi: 10.1155/2012'/125029.
24. D J Su, L F Li. Trends in the use of complementary and alternative medicine in the United States: 2002-2007 [J]. J Health Care for the Poor and Underserved, 2011, 22: 295.
25. C Hawk, H Ndetan, M W Evans. Potential role of complementary and alternative health care providers in chronic disease prevention and health promotion: an analysis of National Health Interview Survey data [J]. Preventive Medicine, 2012, 54: 18.
26. H Xu, K J Chen. Integrative medicine: the experience from China [J]. J Alt Compl Med, 2008, 14(1): 3.
27. H Xu, K J Chen. Integrating traditional medicine with biomedicine towards a patient-centered healthcare system [J]. Chin J Integrative Med, 2011, 17 (2): 83.
28. A B Luiz, I Cordovil, J B Filho, et al. Zangfu zheng (patterns) are associated with clinical manifestations of zang shang (target-organ damage) in arterial hypertension [J]. Chin Med, 2011, 6: 23.
29. R Nahas. Complementary and alternative medicine approaches to blood pressure reduction: an evidence-based review [J]. Can Fam Physician, 2008, 54: 1529.
30. E Ernst. Complementary/alternative medicine for hypertension: a mini-review [J]. Wien Med Wochenschr, 2005, 123: 386.
31. Wang J, Xiong X J. Current situation and perspectives of clinical study in integrative medicine in China [J]. Evid-Based Compl Alt Med, 2008(3): 214.
32. 2007, 5: 255.
33. Buranakitjaren P, Phoojaroenchanachai M, Saravich S. Prevalence of erectile dysfunction among treated hypertensive males [J]. J Med Assoc Thai, 2006, 86(Suppl5): 28.
34. 2009, 23(11): 30.
35. 1998, 18 (6): 336.
36. 2002, 11(2): 94.
37. 2012, 27(11): 2862.
38. 1997, 38(2): 104.
39. 2012, 23(2): 266.
40. 2010, 41(8): 883.
41. 2009, 7(12): 122.
42. 2009, 24(1): 181.
43. 2006, 21(3): 153.
44. 2011, 4(4): 25.
45. 2013, 38(4): 546.
46. Wang J, Wang P Q, Xiong X J. Current situation and re-understanding of syndrome and formula syndrome in Chinese medicine[J]. Internal Med, 2012, doi: 10.4172/2165-8048.1000113.
47. Wang J, Xiong X J. Control strategy on hypertension in Chinese medicine [J]. Evid-Based Compl Alt Med, 2012, doi: 10.1155/2012/284847.
48. Xu H, Chen K J. Making evidence-based decisions in the clinical practice of integrative medicine [J]. Chin J Integrat Med, 2010, 16(6): 483.
49. Xu H, Chen K J. Complementary and alternative medicine: is it possible to be main stream? [J]. Chin J Integrat Med, 2012, 18 (6): 403.